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The effects of ceramides with varying saturated N-linked acyl chains (C2–C14) on cholesterol displacement from sphingomyelin-rich domains
and on the stability of ordered domains were studied. The bilayers examined were made from 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), d-erythro-N-palmitoyl-sphingomyelin (PSM), d-erythro-N-acyl-sphingosine, and cholesterol (60:15:15:10 mol%, respectively).
Cholestatrienol (CTL) or d-erythro-N-trans-parinoyl-sphingomyelin (tParSM) were used as reporter molecules (at 1 mol%) for the ordered
domains, and 1-palmitoyl-2-stearoyl-(7-doxyl)-sn-glycero-3-phosphocholine (7SLPC) as a fluorescence quencher (30 mol%, replacing POPC) in
the liquid-disordered phase. The results indicate that the ceramide had to have an N-linked acyl chain with at least 8 methylene units in order for it
to displace cholesterol from the sphingomyelin-rich domains at the concentration used. The melting of the sphingomyelin-rich domain shifted to
higher temperatures (compared to the ceramide-free control) with C2, C12 and longer chain ceramides, whereas C4–C10 ceramides led to domain
melting at lower temperatures than control. This study shows that short-chain ceramides do not have the same effects on sterol- and
sphingomyelin-rich domains as naturally occurring longer-chain ceramides have.
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Sphingomyelins are major solubilizers of cholesterol in
the plasma membrane compartment in most cell types [1,2].
Sphingomyelins are well suited to interact with cholesterol,
since their acyl chains are long and mostly saturated [3,4],
and since they have more possibilities for hydrogen bonding
as compared with phosphatidylcholines [5,6]. It has been
argued that most of the cellular cholesterol is confined to
plasma membranes [7,8], where a substantial fraction of it is
found in sphingomyelin-rich domains [9,10]. However,
conditions exist where cells appear to enrich plasma
membranes with cholesterol even if their sphingomyelin-
level is markedly reduced [11]. When plasma membrane0005-2736/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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E-mail address: jpslotte@abo.fi (J.P. Slotte).sphingomyelin is enzymatically degraded, the cellular
homeostasis of cholesterol is dramatically changed and
cholesterol is translocated from the cell surface to intracel-
lular membranes [12]. Ceramide is a much less effective
solubilizer of cholesterol than sphingomyelin, in part
because ceramide has no protecting head group to shield
the exposed hydrophobic portions of the molecules [13].
The miscibility of ceramide with sphingomyelin is, on the
other hand, good based on, e.g., DSC analysis of equimolar
mixtures of PSM and C16-ceramide [14]. On a macroscopic
scale, ceramide has also been shown to partition favorably
into sphingomyelin-rich domains [5,12,15]. Very recent data
from both model membrane systems [14,16], lipoproteins
[17], and caveolin-rich lipid rafts [18] show that ceramide is
able to displace cholesterol from sphingomyelin-rich [14,
17,18] or saturated phosphatidylcholine-rich [16] domains. It
was also shown that the partitioning of ceramide into the
sphingomyelin-rich domain (from which cholesterol was
displaced) resulted in a marked stabilization of the cer-
amide/sphingomyelin domain against temperature-induced
melting [14].ta 1718 (2005) 61 – 66
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content of sphingomyelin-rich domains, it would be of interest
to evaluate the effect of ceramide structure on the displacement
process. This would be important in light of the common use of
short-chain and medium-chain ceramides as tools to induce or
inhibit apoptosis in cells [19,20]. It is possible that some of the
effects of ceramides reported in the literature stems from their
effects on cholesterol/sphingomyelin domains rather than from
direct effects on target proteins [21,22]. In this study, we have
used cholestatrienol (CTL) and N-trans parinoyl-sphingo-
myelin (tParSM) as fluorescent probes which partition into
sterol- and sphingomyelin-rich domains, respectively, and 1-
palmitoyl-2-stearoyl-(7-doxyl)-sn-glycero-3-phosphocholine
(7SLPC) as a quencher lipid mainly located in the liquid-di-
sordered phase. We have determined the effect of the ceramide
N-linked chain length (C2–C14) on sterol displacement from
and the temperature-dependent stability of sphingomyelin-rich
domains in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) vesicles containing 10 mol% sterol.2. Material and methods
2.1. Materials
d-erythro-N-palmitoyl-sphingomyelin (PSM) was purified from egg yolk
sphingomyelin (Avanti Polar Lipids, Alabaster, AL, USA) by reverse-phase
HPLC (Supelco Discovery C18-column, dimensions 25021.2 mm, 5 Am
particle size) using 100% methanol as eluent. The purity and identity of the
products were verified on a Micromass Quattro II mass spectrometer
(Manchester, UK). POPC was obtained from Avanti Polar Lipids. (7-
Doxyl)-stearic acid was obtained from TCI (TCI Europe N.V., Belgium) and
was used for the synthesis of 7SLPC [23]. d-erythro-N-acyl-sphingosines
were obtained from Larodan Fine Chemicals (Malmo¨, Sweden) or
synthesized from d-erythro-sphingosine and fatty acid [24]. All products
were characterized by mass spectrometry. Stock solutions of lipids were
prepared in hexane/2-propanol (3:2 by vol), stored in the dark at 20 -C,
and warmed to ambient temperature before use CTL (cholesta-5,7,9(11)-
trien-3-beta-ol) was synthesized and purified using the method published by
Fisher and coworkers [25]. tParSM was synthesized from trans-parinaric
acid (Molecular Probes, Eugene, OR, USA) and d-erythro-sphingosylpho-
sphorylcholine (Matreya LLC, Pleasant Gap, PA, USA) according to Cohen
and co-workers [24]. The fluorescent probes were purified by reverse-phase
HPLC on a RP-18 column with methanol/acetonitrile (70:30, by vol) as
eluent for CTL and 100% methanol for tParSM. All compounds were
positively identified by mass spectrometry. CTL and tParSM were stored
dry under argon in the dark at 87 -C until solubilized in argon-purged
ethanol (CTL) or methanol (tParSM). Stock solutions of fluorescent lipids
were stored in the dark at 20 -C and used within a week.
2.2. Fluorescence quenching method
The F samples contained quencher (7SLPC) and a complex lipid
mixture as described above, while POPC replaced 7SLPC in Fo samples.
The fluorescence intensity in the F samples was compared to the
fluorescence intensity in Fo samples giving the fraction of quenched
fluorescence. In lipid vesicles in which ordered and disordered domains co-
exist, POPC together with the nitroxide labeled quencher (7SLPC) formed
the disordered phase in the vesicles [26]. Fluorophores residing in the
quencher-rich disordered domains give a weaker fluorescence than
fluorophores in the ordered domains, which are quencher-poor. CTL is a
fluorescent cholesterol analogue that has been shown to mimic the
membrane behavior of cholesterol quite well [25,27–30]. In complex lipid
bilayer vesicles, in which lateral domain formation is expected, CTL can beused as a fluorescent sterol analogue that associates with sterol-rich domains
[14]. The amount of CTL exposed to quenching by 7SLPC gives a measure
of CTL distribution between ordered and disordered membrane domains.
The stability of the ordered domains containing CTL is measured by
looking at the quenching susceptibility as a function of temperature. This
quenching method can be used with other fluorescent reporter molecules as
well. In this study, we used CTL and tParSM as fluorescent probes which
partition predominantly into domains enriched in sterol and PSM,
respectively.
2.3. Preparation of vesicles
Vesicles used in steady-state fluorescence measurements were prepared
at a lipid concentration of 50 AM. The lipid mixtures were dried under
nitrogen, dispersed in argon-purged water and heated above the gel- to
liquid-crystalline phase-transition temperature. The samples were vortexed
and then sonicated for 2 min (20% duty cycle, power output 15 W) with a
Branson probe sonifier W-250 (Branson Ultrasonics, CT, USA). This
procedure gives liposomes with a rather large size distribution with a mean
diameter of 200 nm (determined using a Malvern 4700 multiangle laser
spectrometer at an angle of 90-). The water used in the experiments was
purified by reverse osmosis followed by passage through a Millipore UF
Plus water purification system, to yield a product with a resistivity of 18.2
MV cm.
In fluorescence quenching studies, F samples consisted of POPC: 7SLPC:
PSM: ceramide: cholesterol (30:30:15:15:10 molar ratio) and in Fo samples
POPC replaced 7SLPC. The samples were studied with CTL or tParSM as the
fluorescent probe, which replaced cholesterol or PSM, respectively, to give a
final probe concentration of 1 mol%. The fluorescent probes were protected
from light during all steps. Solvents were saturated with argon before use in
order to minimize the risk of oxidation. All experiments were performed in
duplicate or triplicate and curves shown are representative of reproducible
experiments.
2.4. Steady-state fluorescence measurements
Fluorescence measurements were performed on a PTI QuantaMaster-1
spectrofluorimeter (Photon Technology International, Lawrenceville, NJ,
USA). The excitation and emission slits were set to 1–4 nm. The temperature
was controlled by a Peltier element, with a temperature probe immersed in the
sample solution. The samples were heated from 8 -C to 90 -C at a rate of 5 -C/
min during the measurements. The measurements were performed in quartz
cuvettes and the sample solutions were kept at constant stirring (260 rpm)
throughout the measurements. Fluorescence intensity of CTL was detected with
excitation and emission wavelengths at 324 nm and 374 nm, respectively.
Fluorescence emission of tParSM was detected at 410 nm, while excitation
occurred at 305 nm.
3. Results
The basic membrane system examined in this study
contained POPC, PSM and cholesterol (75:15:10). Accord-
ing to the phase diagram of de Almeida and coworkers [31]
the only phases present in such membranes at room
temperature are the liquid disordered phase (Ld) containing
mostly POPC, and the liquid ordered phase (Lo) containing
PSM and most of the cholesterol. The ‘‘melting’’ of the Lo
domains with increasing temperature can be detected using
DSC [32] or CTL quenching [32] (see also Fig. 1). The
amount of CTL exposed to quenching by 7SLPC gives a
measure of CTL distribution between ordered and disordered
membrane domains. The bottom trace in Fig. 1 shows the
change in CTL quenching susceptibility as the temperature
of the sample is increased. The D(F/Fo) change is not very
Fig. 1. Melting of sterol/PSM-rich domains in a fluid bilayer as examined by fluorescence quenching of CTL. For fluorescence quenching experiments, the Fo-
samples were prepared to contain POPC/PSM/sterol (75:15:10 mol%) or POPC/PSM/ceramide(or sphingosine)/sterol (60:15:15:10 mol%). The sterol fraction
contained cholesterol and CTL (9:1, mol/mol). 7SLPC was used as a quencher in F-samples at 30 mol% (replacing some of the POPC). The lipid concentration was
50 AM. The temperature gradient was 5 -C/min.
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seen between 10 and 28 -C. The observed D(F/Fo) is
typical for 15 mol% PSM and 10 mol% sterol, but is larger
when the PSM content in the membrane is higher [14]. To
test the effects of ceramides with varying N-linked acyl
chain lengths on the sterol-rich domains, 15 mol% ceramide
was included in the bilayers during preparation. Both the C2
and the C4 ceramide induced only minor effects on the
D(F/Fo) of CTL fluorescence, whereas C6 ceramide shifted
the melting of the sterol-rich domain to lower temperature
(Fig. 1). In bilayers containing C10, C12, C14 (Fig. 1) or
C16 ceramide [32], the CTL-quenching method did not
report any sterol-rich domain melting, suggesting that these
ceramides were able to completely displace sterol from the
PSM domains. Sphingosine was previously shown to
slightly stabilize sterol/PSM domains using CTL as the
probe [32], so sphingosine is included for the convenience
of the reader again in Fig. 1.
In order to determine the effects of the ceramides on the
stability of the PSM-rich domains, tParSM was used as the
fluorescent probe (Fig. 2). The bottom trace in Fig. 2 is for a
bilayer containing 15 mol% PSM and 10 mol% cholesterol, but
no ceramide. The D(F/Fo) for the quenching of CTL andtParSM in these membranes differ depending on the probe used
(bottom traces in Figs. 1 and 2). The temperature interval for
domain melting was however the same (as expected if PSM
and CTL/cholesterol are in the same domain). Sphingosine and
C2 ceramide appeared to stabilize the PSM domain slightly,
with a similar change in D(F/Fo).
Both C4 and C6 ceramides destabilized the PSM-rich
domains and attenuated the D(F/Fo), indicating that less
ordered domains existed under these conditions. With C8
ceramide, no domain melting could be observed in the
temperature interval analyzed. With longer chain ceramides,
PSM-domain stabilization became again apparent, and this
stabilization was clearly chain-length dependent. C16 ceramide
stabilized the PSM-rich domain even further as compared to
the C14 ceramide [32].
4. Discussion
Although we have not determined the membrane con-
centration of the ceramides, we argue that the actual
concentrations are indeed very close to the prepared
concentrations. The calculated logP (octanol/water partition
coefficient) for the C2 ceramide is 6.14 and higher than that
Fig. 2. Melting of sterol/PSM-rich domains in a fluid bilayer as examined by fluorescence quenching of tParSM. For fluorescence quenching experiments, the Fo-
samples were prepared to contain POPC/PSM/cholesterol (75:15:10 mol%) or POPC/PSM/ceramide (or sphingosine)/cholesterol (60:15:15:10 mol%). The PSM
fraction contained PSM and tParSM (14:1, mol/mol). 7SLPC was used as a quencher in F-samples at 30 mol% (replacing some of the POPC). The lipid
concentration was 50 AM. The temperature gradient was 5 -C/min. The scale bar D( F/Fo) 0.2 applies to the five lower curves, whereas the scale bar D( F/Fo) 0.4
applies to the four upper curves.
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values varied linearly between 6.14 and 12.48 for ceramide
chain lengths C2 to C14 (data not shown). Sphingosine was
previously shown by us to stabilize PSM domains under
similar conditions used in this study (this study and [32]),
indicating that its membrane concentration was significant.
The critical micelle concentration of sphingosine has been
reported to be around 112 AM [33]. Also the most ‘‘water-
soluble’’ of our ceramides (C2 ceramide) clearly stabilized
PSM domains (Fig. 2) suggesting it had a significant
membrane concentration. Although the short-chain ceramides
are considered ‘‘water-soluble’’, their cmc is only 5–6 AM
[34], which is three orders of magnitude less than the
critical micelle concentration of deoxycholate, which was
shown by us to have a fairly high membrane partition
coefficient (2200 M1 with egg yolk sphingomyelin
vesicles) [35]. All these things considered, and since these
short-chain ceramide sphingolipids in general have an
affinity for other sphingolipids (in this case PSM [15]),
we are confident that their membrane concentration is close
to the prepared concentration.The C2 ceramide resembles sphingosine more than it
does a natural ceramide, with the N-acetyl chain at the
water/lipid interface (Fig. 3). The effects of the C2 ceramide
in this study were very similar to the effects observed with
sphingosine in a similar membrane system [32], suggesting
that it co-existed with the sterol in the PSM-rich domain. It
is interesting to note that both sphingosine and C2-ceramide
can be pro-apoptotic in cells [36,37], whereas C6 and longer
ceramides can be potent inhibitors of apoptosis.
The acyl chain of the C4 ceramide will most likely
influence the interfacial lipid packing in its vicinity, since
the C4 chain probably wobbles between the aqueous phase
and the more hydrophobic interface (Fig. 3). In our system
C4 ceramide disturbed the lipid packing in the sterol/PSM-
rich domain, partially destabilizing them, (Figs. 1 and 2) but
was not capable to displace a lot of sterol from the domains
(Fig. 1). The C6 ceramide behaved similarly, although the
melting temperature of the domains was further decreased
(Figs. 1 and 2). It may be argued that short-chain ceramides
may form micelles in membranes which at higher tempera-
tures actually may be expelled from the bilayers. However,
Fig. 3. CPK models of sphingosine (C0) and the different ceramides (C2–C14)
used in the study. Energy-minimized models were prepared in Chem3D
(Cambridge Software, MA, USA) and combined and visualized using DS
ViewerPro 5.0 (Accelrys Inc.).
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tParSM as probes), the quenching curves were almost
identical during temperature up-scan and down-scan (data not
shown), implying that it is very unlikely that these short-chain
ceramides induced irreversible micellization during the heating
scans.
It is interesting here to note that while C2 ceramide
destabilized the lamellar-to-hexagonal phase transition of
dielaidoylphosphatidylethanolamine bilayers [38], the C6
ceramide actually stabilized the same transition [38], possibly
implying that the C6 acyl chain in fact is partially embedded in
the phosphatidylethanolamine bilayer giving the ceramide
molecule an inverted cone shape. The membrane packing of
the C6 chain in the ceramide may not, however, be identical in
a sphingomyelin-rich environment which has a different
interfacial hydration. The acyl chain of the C8 ceramide is
probably long enough to be partially embedded within the
bilayer interface. C8 ceramide displaced sterol from the PSM-
domains and destabilized them (no melting with either probe
can be detected above 10 -C). Ceramides with C10 to C14
displaced all sterol from the PSM-domains and a clear
ceramide-induced stabilization of the PSM-domains was
evident (Fig. 2). When the acyl chain of the ceramides are
C10 or longer they are very likely to be completely in the
bilayer, adjacent to the neighboring long-chain bases or acyl
chains (Fig. 3). In a study of the membrane properties of N-acyl
phosphatidylethanolamines, it was observed that the N-linked
acyl chain had to have at least 10 methylene units before it was
embedded in the bilayer [39,40]. Although the N-linked acyl
chain must have a slightly different membrane affinitydepending on its attachment to a phosphorylethanolamine head
group or to a long chain base, our results agree reasonably well
with the studies reported in [39,40].
Taken together, our results show that although all tested
ceramides appeared to partition into PSM-rich domains, their
effect on the sterol composition of the PSM-domains varied
markedly with the N-linked acyl chain length. Only medium
and long-chain ceramides could displace sterol from PSM-rich
domains at the selected concentration. The effect of the
ceramides on the stability of the PSM-rich domains was also
markedly influenced by the ceramide N-linked chain length.
Strong stabilization of the PSM-rich domains was seen only
with C12 and longer ceramides, whereas the short-chain
ceramides mostly destabilized the PSM-rich domains. Since
ceramides generated in situ using sphingomyelinase have been
shown to induce membrane leakage [41], ceramide aggregation
into domains [42], and transmembrane scrambling of lipids
[43], it would be of some interest to correlate those ceramide
effects with the length of the N-linked acyl chain in order to
better understand how they are influenced by the molecular
shape of the ceramides.
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